Simplex Trading’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.08M | Sell |
7,800
-22,000
| -74% | -$5.14M | ﹤0.01% | 2007 |
|
|
2026
Q1 | $6.82M | Sell |
29,800
-7,300
| -20% | -$1.64M | ﹤0.01% | 899 |
|
|
2025
Q4 | $7.91M | Buy |
37,100
+2,600
| +8% | +$537K | ﹤0.01% | 1001 |
|
|
2025
Q3 | $6.86M | Buy |
34,500
+23,400
| +211% | +$4.36M | ﹤0.01% | 1204 |
|
|
2025
Q2 | $1.92M | Buy |
11,100
+7,900
| +247% | +$1.29M | ﹤0.01% | 2153 |
|
|
2025
Q1 | $498K | Buy |
3,200
+300
| +10% | +$42.9K | ﹤0.01% | 3411 |
|
|
2024
Q4 | $399K | Sell |
2,900
-1,000
| -26% | -$131K | ﹤0.01% | 3775 |
|
|
2024
Q3 | $582K | Sell |
3,900
-5,300
| -58% | -$716K | ﹤0.01% | 3436 |
|
|
2024
Q2 | $1.25M | Buy |
9,200
+3,400
| +59% | +$463K | ﹤0.01% | 2687 |
|
|
2024
Q1 | $876K | Buy |
5,800
+5,200
| +867% | +$742K | ﹤0.01% | 3257 |
|
|
2023
Q4 | $75K | Sell |
600
-11,100
| -95% | -$1.11M | ﹤0.01% | 5658 |
|
|
2023
Q3 | $1.09M | Sell |
11,700
-3,500
| -23% | -$327K | ﹤0.01% | 2573 |
|
|
2023
Q2 | $1.36M | Sell |
15,200
-44,800
| -75% | -$3.9M | ﹤0.01% | 2313 |
|
|
2023
Q1 | $6.43M | Buy |
60,000
+50,100
| +506% | +$5.73M | 0.01% | 1141 |
|
|
2022
Q4 | $1.21M | Sell |
9,900
-3,000
| -23% | -$348K | ﹤0.01% | 2289 |
|
|
2022
Q3 | $1.33M | Sell |
12,900
-1,200
| -9% | -$114K | ﹤0.01% | 2340 |
|
|
2022
Q2 | $1.31M | Sell |
14,100
-5,200
| -27% | -$490K | ﹤0.01% | 2327 |
|
|
2022
Q1 | $2.27M | Buy |
19,300
+18,800
| +3,760% | +$2.18M | ﹤0.01% | 1984 |
|
|
2021
Q4 | $67K | Hold |
500
| – | – | ﹤0.01% | 6822 |
|
|
2021
Q3 | $67K | Hold |
500
| – | – | ﹤0.01% | 7139 |
|
|
2021
Q2 | $65K | Buy |
500
+496
| +12,400% | +$66.1K | ﹤0.01% | 7301 |
|
|
2021
Q1 | $51K | Sell |
4
-15
| -79% | -$2.28K | ﹤0.01% | 6590 |
|
|
2020
Q4 | $316K | Buy |
19
+14
| +280% | +$2.31K | ﹤0.01% | 3999 |
|
|
2020
Q3 | $77K | Sell |
5
-7
| -58% | -$1.01K | ﹤0.01% | 5176 |
|
|
2020
Q2 | $177K | Sell |
12
-2
| -14% | -$275 | ﹤0.01% | 4125 |
|
|
2020
Q1 | $157K | Sell |
14
-147
| -91% | -$19.1K | ﹤0.01% | 3865 |
|
|
2019
Q4 | $2.24M | Buy |
161
+139
| +632% | +$15.4K | ﹤0.01% | 1386 |
|
|
2019
Q3 | $211K | Buy |
22
+4
| +22% | +$446 | ﹤0.01% | 3507 |
|
|
2019
Q2 | $207K | Sell |
18
-203
| -92% | -$24.3K | ﹤0.01% | 3431 |
|
|
2019
Q1 | $2.6M | Buy |
221
+169
| +325% | +$14.8K | 0.01% | 1140 |
|
|
2018
Q4 | $325K | Sell |
52
-61
| -54% | -$3.83K | ﹤0.01% | 2637 |
|
|
2018
Q3 | $800K | Buy |
113
+110
| +3,667% | +$7.57K | ﹤0.01% | 2111 |
|
|
2018
Q2 | $19K | Buy |
+3
| New | +$197 | ﹤0.01% | 5887 |
|
Other funds holding ASND
RCM
ACA
JT
Simplex Trading's ASND Position: Q2 2026 in Review
Simplex Trading opened a new position in Ascendis Pharma A/S (ASND) in Q2 2026: 8,275 shares worth $2.21M. The stake represents ﹤0.01% of the portfolio and ranks #1936 among its holdings. This is a return to the name: Simplex Trading previously reported a position in ASND as recently as Q4 2024.
Simplex Trading first reported a position in ASND in Q2 2018 and has held it in 17 quarters since. 312 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Simplex Trading held 8,275 shares of Ascendis Pharma A/S worth $2.21M as of Q2 2026.
- Ascendis Pharma A/S was a new Simplex Trading position in Q2 2026.
- Ascendis Pharma A/S made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1936 holding.
- Simplex Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 17 quarters since.
- 312 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.